It has been proposed that the nuclearexport of HDAC5 responds to hypertrophic stimuli, contributing to pathologicalhypertrophy; therefore, inhibiting HDAC5 could be a viable approach to counteractcardiac hypertrophy (CH) [66]. Here, HDAC5 is linked to cyclic hematopoiesis.